Orexo announces that the condition for early redemption of its existing bonds has been fulfilled

For further information on the early redemption, see the Company's press release on March 13, 2024, and the notice of early redemption which is available on the Company's website. For further information on the early redemption, see the Company's press release onMarch 13, 2024, and the notice of early redemption which is available on the Company's website. For further information please contact: Nikolaj Sørensen, President and CEO Fredrik Järrsten, EVP and CFOLena Wange, IR &...

For further information on the early redemption, see the Company's press release on March 13, 2024, and the notice of early redemption which is available on the Company's website.

For further information please contact:

Nikolaj Sørensen, President and CEO
Fredrik Järrsten, EVP and CFO
Lena Wange, IR & Communications Director
Tel: +46 (0)18 780 88 00
E-mail: ir@orexo.com

About Orexo

Orexo is a Swedish pharmaceutical company with over 25 years of experience developing improved pharmaceuticals based on proprietary formulation technologies that meet large medical needs. On the US market, Orexo provides innovative treatment solutions for patients suffering from opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with leading partners. Total net sales in 2023 amounted to SEK 639 million, and the number of employees to 116. Orexo is listed on Nasdaq Stockholm's main list and is available as an ADR on OTCQX (ORXOY) in the US.

For more information about Orexo please visit www.orexo.com. You can also follow Orexo on X, LinkedIn, and YouTube.

The information was sent for publication, through the agency of the contact person set out above, on April 2, 2024, at 1.15 pm CET.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/orexo/r/orexo-announces-that-the-condition-for-early-redemption-of-its-existing-bonds-has-been-fulfilled,c3955093

The following files are available for download:

 

View original content:https://www.prnewswire.co.uk/news-releases/orexo-announces-that-the-condition-for-early-redemption-of-its-existing-bonds-has-been-fulfilled-302105698.html